Jeanie Ling, MD

Kelsey-Seybold Medical Group Provider
PointerLanguage(s): English, Mandarin
2727 W. Holcombe Blvd.,
Houston,
TX
77025
Joined Kelsey-Seybold: August 2018
Ways to Schedule an Appointment
My Video Profile
"I strive for the best possible patient outcomes and to provide a full range of services in patient care and education. I believe in engaging patients and families as partners in healing."
My Biography
-
Professional Background
-
Professional Associations
-
Hobbies and Interests
-
Awards & Publications
Dr. Jeanie Ling completed her medical degree in 2013 from Baylor College of Medicine in Houston. She completed her residency in Ophthalmology in 2017 at Vanderbilt University Medical Center in Nashville. She also completed her Fellowship in glaucoma at The University of Texas Houston Health Science Center in 2018. After graduation, Dr. Ling joined Kelsey-Seybold’s Ophthalmology Department in August 2018 and cares for patients at the Berthelsen Main Campus and Tanglewood Clinic.
Dr. Ling is a member of the Texas Medical Association, the American Academy of Ophthalmology, American Glaucoma Society, and the Association for Research in Vision and Ophthalmology.
Dr. Ling enjoys photography, opera, dance, and travel.
Fun Facts
Dr. Ling’s one guilty pleasure is reading detective novels. The most exotic or interesting places she’s visited are Morocco, Nepal, and India.
Dr. Ling has received multiple awards, the most recent of which was a New World Medical Humanitarian Fellowship in 2017.
Publications
- Ling JD, Hashemi N, Lee AG. Giant cell arteritis first presenting as throat pain. Journal of Neuro-ophthalmology. 2012 Dec; 32(4): 384.
- Ling JD, Chao D, Al Zubidi N, Lee AG. Big red flags in neuro-ophthalmology. Can J Ophthalmol. 2013 Feb; 48(1):3-7.
- Ling JD, Gire A, Pflugfelder S. PROSE Therapy Used to Minimize Corneal Trauma in Patients with Corneal Epithelial Defects. Am J Ophthalmol. 2013 Apr; 155(4):615-619.
- Al Zubidi N, Ling JD, Lee AG. Atonic pupils secondary to presumed systemic vasopressor-related ischemia. Can J Ophthalmol. 2013 Oct; 48(5):e123-4.
- Nafiseh H, Ling JD, Soparker C, Sami M, Ellezam B, Klucznik R, Lee AG, Chévez-Barrios P. Onyx transarterial embolization of an orbital solitary fibrous tumor. Ocul Oncol Pathol 2015;1:98–102.
- Patel S, Ling JD, Kim SJ, Schey KL, Rose K, Kuchtey RW. Proteomic Analysis of Macular Fluid Associated With Advanced Glaucomatous Excavation. JAMA Ophthalmol. 2016 Jan 1;134(1):108-10.
- Ling JD, Joos KM. A Successful Early Postoperative Shunt Plate Erosion Repair-Case Report. Advances in Ophthalmology & Visual Systems. 2015; 3(2): 82.
- Ling JD, Mehta V, Fathy C, Rapoport Y, Zhang M, Daniels A, Kohanim S. Racial Disparities in Corneal Transplantation Rates, Complications, and Outcomes. Seminars in Ophthalmology. 2016 Apr 19:0.
- Mehta V, Ling JD, Mawn L. Socioeconomic Disparities in the Presentation of Acute Bacterial Sinusitis Complications in the Pediatric Population. 2016 Apr 29:1-4.
- Gregory AC 2nd, Zhang MM, Rapoport Y, Ling JD, Kuchtey RW. Racial Influences of Uveitic Glaucoma: Consolidation of Current Knowledge of Diagnosis and Treatment. Semin Ophthalmol. 2016 Apr 21:0.
- Rapoport Y, Singer JM, Ling JD, Gregory A, Kohanim S. A Comprehensive Review of Sex Disparities in Symptoms, Pathophysiology, and Epidemiology of Dry Eye Syndrome. Semin Ophthalmol. 2016 Apr 21:0.
- Zhang M, Tanaka S, Mercier M, Hollar M, Ling JD, Gregory A, Barahimi B. Gender and Racial Disparities in Cases of Autoenucleation. Semin Ophthalmol. 2016 May 4:0.
- Ling J, Mehta V, Reddy A, Hollar M, Donahue S. An abnormal ocular motor manifestation of Joubert syndrome. J AAPOS. 2017 Feb;21(1):75-77.
- Ling J, Tauscher R, Mehta V, Zhang M, Daniels A, Kohanim S. The Role for Sentinel Lymph Node Biopsy in the Management of Conjunctival Melanoma. Int Ophthalmol Clin. 2017 Winter;57(1):87-101.
- Mehta VJ, Ling J, Sobel RK. Review of Targeted Therapies for Periocular Tumors. Int Ophthalmol Clin. 2017 Winter;57(1):153-168.
Presentations and abstracts
- Ling JD, Arlinghaus RB, Ling X. Vaccination with Leukemia Cell Expression Membrane Bound GM-CSF Overcomes the Host Immunosuppression Induced by Leukemia. Blood (ASH Annual Meeting Abstracts) 2008 112: Abstract 5435.
- Ling JD, Fathy C, Kohanim S. Pediatric Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis: epidemiology and risk factors for ocular involvement. ARVO 2016. 1537 - A0362.
- Ling JD, Shah AA, Nathan NR, Chen Q, Seibold LK, Kammer JA. Comparison of femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification cataract surgery (CPCS) in glaucoma, ocular hypertension, and glaucoma suspect patients. AAO 2016.
Research
- Cancer Research, 2007-2008
To study the effect of vaccination against leukemia with leukemia cell expressing membrane bound GM-CSF in mice
Mentor: Ralph Arlinghaus, Ph.D.,
MD Anderson Cancer Center, Houston - Ophthalmology Research, 2012
To study the effect of PROSE therapy in treating recurrent corneal erosion refractory to soft contact lens
Mentor: Stephen Pflugfelder, M.D.
Baylor College of Medicine, Houston - Ophthalmology Research, 2015-2018
To compare the presence of caveolin-1 in the retinas of normotensive and ocular hypertensive aged DBA/2J mice.
Mentor: Karen Joos, M.D., Ph.D.
Vanderbilt Eye Institute, Nashville, Tenn. - Ophthalmology Research, 2015-2018
Risk factors and demographics of ocular involvement in pediatric erythema multiforme (EM), Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN).
Mentor: Sahar Kohanim, M.D., M.P.H
Vanderbilt Eye Institute, Nashville, Tenn. - Ophthalmology Research, 2016-2018
Outcomes of femtosecond laser-assisted cataract surgery in glaucoma, glaucoma suspect, and ocular hypertension patients
Mentor: Jeffrey Kammer, M.D.
Vanderbilt Eye Institute, Nashville, Tenn.
Accepted Insurance
-
Humana Plans
Humana
- KelseyCare Humana (learn more)
- Humana Choice POS
- Humana COT National POS Open Access
- Humana EPO PPO Open Access
- Humana National EPO
- Humana HMO Premier (Open Access)
- Humana PPO
- Humana Preferred PPO
- Humana Preferred POS (Open Access)
- Humana/ ChoiceCare Network PPO
- Humana/ChoiceCare+ Network PPO
- Humana National POS- Open Access
- Humana National POS-Open Access Plus
-
Blue Cross Blue Shield Plans
Blue Cross Blue Shield
The specific BCBSTX PPO and HMO plans in which Kelsey-Seybold participates are:
- Blue Edge PPO
- Blue Essentials HMO Click here to learn more about selecting a Kelsey Primary Care Physician
- Blue Choice PPO
- Blue Cross Blue Shield of Texas
- Blue Cross Blue Shield Federal Employee Program (Basic and Standard Option)
- Health Select of Texas - ERS
- TRS-ActiveCare Primary Click here to learn more about selecting a Kelsey Primary Care Physician
- TRS-ActiveCare Primary+ Click here to learn more about selecting a Kelsey Primary Care Physician
- TRS-ActiveCare HD
- TRS-ActiveCare 2
- UT SELECT
Kelsey-Seybold will not participate in the following BCBSTX plans: Blue Premier, Blue High-Performance network, Marketplace plans: My Blue Health, and Blue Advantage HMO, or any BCBSTX Medicare products.View FAQ (pdf)
-
Cigna Plans
Cigna
- KelseyCare powered by Cigna (learn more)
- Choice Fund PPO
- Choice Fund Open Access Plus (OAP)
- Cigna EPO
- Cigna HMO
- Cigna KelseyCare
- Cigna HMO Open Access (OA)
- Cigna HMO Open Access Plus (OAP)
- Cigna POS
- Cigna PPO
- Cigna Consumer Driven Health Plan (CDHP)
- Cigna Surefit
- LocalPlus
- LocalPlus IN
-
UnitedHealthcare Plans
UnitedHealthcare (UHC)
- United Charter Kelsey-Seybold (learn more)
- UnitedHealthcare Charter
- UnitedHealthcare Choice
- UnitedHealthcare Choice Plus
- UnitedHealthcare Core
- UnitedHealthcare Core Plus
- UnitedHealthcare Navigate
- UnitedHealthcare Navigate Plus
- UnitedHealthcare NexusACO
- UnitedHealthcare Options PPO
- UnitedHealthcare Select
- UnitedHealthcare Select Plus
-
Aetna Plans
Aetna KelseyCare (learn more)
Aetna PPO, POS, and EPO Plans
Kelsey-Seybold Clinic is an in-network provider for most Aetna PPO, POS, and EPO plans*, including:
- Aetna Select
- Open Access Select
- Elect Choice
- Aetna Open Access Elect Choice
- Aetna Choice POS II
- Managed Choice
- Open Choice PPO
Aetna CVS Health Marketplace Plans
Effective January 1, 2023
- Bronze S
- Silver 1
- Silver 2
- Silver 3
- Silver 4
- Silver S
- Gold
- Gold S
*All Houston area Aetna CVS Health plans are accepted at Kelsey-Seybold Clinic*
*Kelsey-Seybold does not participate in any commercial Aetna HMO and HNO plans, including Aetna QPOS.
-
KelseyCare Health Plans
Local employers can add a KelseyCare plan alongside current plan offerings. Over 400 Houston-area employers offer the choice of a KelseyCare plan to their employees.
KelseyCare plans include:
- Aetna KelseyCare (learn more)
- KelseyCare powered by Cigna (learn more)
- KelseyCare Humana (learn more)
- United Charter Kelsey-Seybold (learn more)
-
Other Plans
Allied Benefit Systems/NGBS
Federal Employee Health Benefits (FEHB)
- APWU Health Plan Nationwide – CDHP with UnitedHealthcare PPO
- APWU Health Plan Nationwide – High Option with Cigna PPO
- GEHA Benefit Plan Nationwide – High & Standard Options with UnitedHealthcare Choice Plus
- NALC Nationwide with Cigna OAP
- NALC Value Option Nationwide with Cigna OAP
- SAMBA Nationwide – High & Standard with Cigna OAP
- Blue Cross Blue Shield – Standard Option
- Blue Cross Blue Shield – Basic Option
First Health
Great West Healthcare (also known as Cigna-GWH)
- POS
- PPO
- Open Access
HealthSmart PPO
Medicare
Kelsey-Seybold Clinic accepts the following Medicare Advantage Plans: KelseyCare Advantage, Aetna Medicare Advantage, WellCare TexanPlus, Humana Medicare and select UnitedHealthcare plans. Effective January 1, 2009, Kelsey-Seybold Clinic does not accept new patients with traditional Medicare.
MultiPlan PPO
Private Healthcare Systems PPO (PHCS)
-
Medicare Advantage Plans